vs

Side-by-side financial comparison of Biofrontera Inc. (BFRI) and INTERGROUP CORP (INTG). Click either name above to swap in a different company.

INTERGROUP CORP is the larger business by last-quarter revenue ($17.3M vs $17.1M, roughly 1.0× Biofrontera Inc.). Biofrontera Inc. runs the higher net margin — 33.0% vs 8.8%, a 24.2% gap on every dollar of revenue. On growth, Biofrontera Inc. posted the faster year-over-year revenue change (36.2% vs 19.8%). INTERGROUP CORP produced more free cash flow last quarter ($-481.0K vs $-2.4M). Over the past eight quarters, Biofrontera Inc.'s revenue compounded faster (47.0% CAGR vs 7.8%).

Biofrontera Inc. is a specialty biopharmaceutical enterprise focused on developing and commercializing prescription dermatological products. Its core product line targets skin conditions including actinic keratosis and other dermatological disorders, with primary operating markets in the United States and European Union, serving patients and dermatology care providers.

Intergroup Corp is a diversified holding firm operating two core segments: real estate and hotel operations. It owns, manages and leases commercial and residential properties across the U.S., and runs limited-service hotels for leisure and business travelers.

BFRI vs INTG — Head-to-Head

Bigger by revenue
INTG
INTG
1.0× larger
INTG
$17.3M
$17.1M
BFRI
Growing faster (revenue YoY)
BFRI
BFRI
+16.4% gap
BFRI
36.2%
19.8%
INTG
Higher net margin
BFRI
BFRI
24.2% more per $
BFRI
33.0%
8.8%
INTG
More free cash flow
INTG
INTG
$1.9M more FCF
INTG
$-481.0K
$-2.4M
BFRI
Faster 2-yr revenue CAGR
BFRI
BFRI
Annualised
BFRI
47.0%
7.8%
INTG

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
BFRI
BFRI
INTG
INTG
Revenue
$17.1M
$17.3M
Net Profit
$5.6M
$1.5M
Gross Margin
Operating Margin
26.6%
11.6%
Net Margin
33.0%
8.8%
Revenue YoY
36.2%
19.8%
Net Profit YoY
504.0%
155.6%
EPS (diluted)
$0.62
$0.71

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BFRI
BFRI
INTG
INTG
Q4 25
$17.1M
$17.3M
Q3 25
$7.0M
$17.9M
Q2 25
$9.0M
$16.2M
Q1 25
$8.6M
$16.8M
Q4 24
$12.6M
$14.4M
Q3 24
$9.0M
$16.9M
Q2 24
$7.8M
$13.4M
Q1 24
$7.9M
$14.9M
Net Profit
BFRI
BFRI
INTG
INTG
Q4 25
$5.6M
$1.5M
Q3 25
$-6.6M
$-535.0K
Q2 25
$-5.3M
$-2.2M
Q1 25
$-4.2M
$-578.0K
Q4 24
$-1.4M
$-2.7M
Q3 24
$-5.7M
$-398.0K
Q2 24
$-257.0K
$-4.9M
Q1 24
$-10.4M
$-3.2M
Operating Margin
BFRI
BFRI
INTG
INTG
Q4 25
26.6%
11.6%
Q3 25
-89.8%
15.3%
Q2 25
-56.2%
8.1%
Q1 25
-52.9%
14.0%
Q4 24
-13.6%
5.9%
Q3 24
-55.0%
18.5%
Q2 24
-64.7%
3.7%
Q1 24
-69.1%
4.8%
Net Margin
BFRI
BFRI
INTG
INTG
Q4 25
33.0%
8.8%
Q3 25
-95.1%
-3.0%
Q2 25
-59.0%
-13.9%
Q1 25
-48.9%
-3.4%
Q4 24
-11.1%
-18.9%
Q3 24
-62.9%
-2.4%
Q2 24
-3.3%
-36.7%
Q1 24
-131.9%
-21.3%
EPS (diluted)
BFRI
BFRI
INTG
INTG
Q4 25
$0.62
$0.71
Q3 25
$-0.62
$-0.25
Q2 25
$-0.57
Q1 25
$-0.47
$-0.27
Q4 24
$0.69
$-1.26
Q3 24
$-0.98
$-0.18
Q2 24
$-0.05
Q1 24
$-2.88
$-1.44

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BFRI
BFRI
INTG
INTG
Cash + ST InvestmentsLiquidity on hand
$6.4M
$7.5M
Total DebtLower is stronger
$233.2M
Stockholders' EquityBook value
$10.5M
$-85.2M
Total Assets
$28.6M
$101.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BFRI
BFRI
INTG
INTG
Q4 25
$6.4M
$7.5M
Q3 25
$3.4M
$6.0M
Q2 25
$7.2M
$6.1M
Q1 25
$1.8M
$4.8M
Q4 24
$5.9M
$15.4M
Q3 24
$2.9M
$12.2M
Q2 24
$4.4M
$11.6M
Q1 24
$3.8M
$19.5M
Total Debt
BFRI
BFRI
INTG
INTG
Q4 25
$233.2M
Q3 25
$237.8M
Q2 25
$240.5M
Q1 25
$241.5M
Q4 24
$227.2M
Q3 24
$218.1M
Q2 24
$225.7M
Q1 24
$225.0M
Stockholders' Equity
BFRI
BFRI
INTG
INTG
Q4 25
$10.5M
$-85.2M
Q3 25
$-2.6M
$-86.7M
Q2 25
$-4.7M
$-86.1M
Q1 25
$500.0K
$-84.5M
Q4 24
$4.4M
$-83.9M
Q3 24
$5.5M
$-80.9M
Q2 24
$10.9M
$-80.3M
Q1 24
$-5.4M
$-76.4M
Total Assets
BFRI
BFRI
INTG
INTG
Q4 25
$28.6M
$101.1M
Q3 25
$15.4M
$102.5M
Q2 25
$20.1M
$104.1M
Q1 25
$16.6M
$103.2M
Q4 24
$22.1M
$110.6M
Q3 24
$18.5M
$109.3M
Q2 24
$21.6M
$107.8M
Q1 24
$24.6M
$119.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BFRI
BFRI
INTG
INTG
Operating Cash FlowLast quarter
$-2.4M
$-23.0K
Free Cash FlowOCF − Capex
$-2.4M
$-481.0K
FCF MarginFCF / Revenue
-13.9%
-2.8%
Capex IntensityCapex / Revenue
0.0%
2.6%
Cash ConversionOCF / Net Profit
-0.42×
-0.02×
TTM Free Cash FlowTrailing 4 quarters
$-13.4M
$739.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BFRI
BFRI
INTG
INTG
Q4 25
$-2.4M
$-23.0K
Q3 25
$-3.8M
$-296.0K
Q2 25
$-3.0M
$5.9M
Q1 25
$-4.1M
$-854.0K
Q4 24
$-1.0M
$-781.0K
Q3 24
$-1.2M
$3.4M
Q2 24
$-4.7M
$6.8M
Q1 24
$-3.3M
$1.9M
Free Cash Flow
BFRI
BFRI
INTG
INTG
Q4 25
$-2.4M
$-481.0K
Q3 25
$-3.8M
$-1.3M
Q2 25
$-3.0M
$3.6M
Q1 25
$-4.1M
$-1.2M
Q4 24
$-1.0M
$-1.1M
Q3 24
$3.1M
Q2 24
$-4.8M
$2.7M
Q1 24
$-3.4M
$1.1M
FCF Margin
BFRI
BFRI
INTG
INTG
Q4 25
-13.9%
-2.8%
Q3 25
-54.7%
-7.1%
Q2 25
-33.7%
22.5%
Q1 25
-48.0%
-6.8%
Q4 24
-8.1%
-7.8%
Q3 24
18.3%
Q2 24
-60.8%
20.4%
Q1 24
-42.7%
7.6%
Capex Intensity
BFRI
BFRI
INTG
INTG
Q4 25
0.0%
2.6%
Q3 25
0.0%
5.4%
Q2 25
0.0%
13.9%
Q1 25
0.0%
1.8%
Q4 24
0.0%
2.4%
Q3 24
0.0%
1.6%
Q2 24
0.6%
30.4%
Q1 24
0.7%
4.9%
Cash Conversion
BFRI
BFRI
INTG
INTG
Q4 25
-0.42×
-0.02×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BFRI
BFRI

Segment breakdown not available.

INTG
INTG

Hotel Operations$12.7M73%
Real Estate Operation$4.6M27%

Related Comparisons